This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tietjen, C. S. Articles by Traystman, R. J. Search for Related Content PubMed PubMed Citation Articles by Tietjen, C. S. Articles by Traystman, R. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Medline Plus Health Information Brain Diseases

(Stroke. 1995;26:2160-2165.)
© 1995 American Heart Association, Inc.

Articles

Time-Dependent Inhibition of Oxotremorine-Induced Cerebral Hyperemia by N-Nitro-L-Arginine in Cats

Charisse S. Tietjen, MD; Jeffrey R. Kirsch, MD; Nathalie Clavier, MD Richard J. Traystman, PhD

From the Department of Anesthesiology/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Md.

Correspondence to Jeffrey R. Kirsch, MD, Blalock 1410, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287-4963.

Background and Purpose Oxotremorine (OXO) is a cholinergic agonist that increases cerebral blood flow (CBF) when administered intravenously. We tested the hypothesis that OXO causes a dose-related increase in CBF in cats via a muscarinic mechanism that involves stimulation of nitric oxide synthase.

Methods Halothane-anesthetized male cats were studied under controlled ventilation. In three groups we measured cerebral blood flow (CBF; microspheres) during 30 minutes of intravenous OXO infusion at doses of 0.5 (n=3), 5 (n=6), or 50 µg · kg^-1 · min^-1 (n=6). The role of muscarinic receptor activation in the CBF response to OXO (50 µg · kg^-1 · min^-1) was assessed by determining the effect of atropine sulfate (2 mg · kg^-1, n=6) pretreatment in a separate group of cats. The role of nitric oxide synthase was assessed by determining the CBF response to OXO (50 µg · kg^-1 · min^-1) either 30 (n=6) or 60 minutes (n=5) after administration of 50 mg/kg N-nitro-L-arginine (LNA).

Results CBF to forebrain (pre-OXO, 144±12 mL · min^-1 ·100 g^-1) was unchanged with OXO 0.5 or 5 µg · kg^-1 · min^-1 but increased at 10 (209±26 mL · min^-1 · 100 g^-1) and 30 minutes (243±35 mL · min^-1 · 100 g^-1) of OXO infusion at 50 µg · kg^-1 · min^-1 (P<.05). Atropine sulfate prevented OXO-induced hyperemia at 10 minutes of infusion but not at 30 minutes of infusion (135±12% of pre-OXO). LNA decreased baseline CBF by approximately 50%. Treatment with LNA 30 minutes before OXO did not affect the extent of OXO-induced hyperemia (CBF, 142±15% of pre-OXO at 10 minutes and 153±18% of pre-OXO at 30 minutes of OXO infusion). Treatment with LNA 60 minutes before OXO ablated OXO-induced hyperemia.

Conclusions In halothane-anesthetized cats, OXO (50 µg · kg^-1 · min^-1) increases forebrain CBF by a muscarinic mechanism that involves stimulation of nitric oxide synthase. The ability of nitric oxide synthase inhibitors to block agonist-induced nitric oxide–mediated vasodilation (response to OXO) is time dependent and may not be predicted by ability of the inhibitor to significantly decrease basal CBF.

Key Words: cerebral blood flow • hypoxia • nitric oxide • oxygen • cats

This article has been cited by other articles:

				S. B Felix, V. Stangl, T. M Frank, C. Harms, T. Berndt, R. Kastner, and G. Baumann Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion Cardiovasc Res, July 1, 1997; 35(1): 68 - 79. [Abstract] [Full Text] [PDF]